• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ImmunoGen Inc

+ Add to Watchlist

IMGN:US

10.7250 USD 0.8950 9.10%

As of 20:10:00 ET on 12/17/2014.

Company Profile for ImmunoGen Inc (IMGN)

ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.

Contact Information

ImmunoGen Inc

830 Winter Street
Waltham, MA 02451-1477
United States
Phone: 1-781-895-0600
Fax: 1-781-895-0611

Key Executives for ImmunoGen Inc (IMGN)

Daniel M Junius "Dan"President/CEODavid B Johnston "Dave"Exec VP/CFO
John M LambertExec VP/Chief Scientific OfcrSandra E PooleSenior VP:Technical Operations
Charles Q Morris "Charlie"VP/Chief Development OfficerEllie HarrisonVP/Chief Human Resources Ofcr
Craig BarrowsVP/Secretary/General CounselPeter J WilliamsVP:Business Development
Carol HausnerExec Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil